Design and synthesis of unprecedented 9- and 10-membered cyclonucleosides with PRMT5 inhibitory activity

Shuhei Kawamura1, Rachel L Palte2, Hai-Young Kim3

  • 1Discovery Chemistry, Merck & Co., Inc., Boston, MA 02115, United States.